Todd Wills

Summary

Affiliation: University of South Florida
Country: USA

Publications

  1. doi request reprint Elvitegravir: a once-daily inhibitor of HIV-1 integrase
    Todd Wills
    Division of Infectious Disease and International Medicine, University of South Florida College of Medicine, 1 Tampa General Circle, Tampa, FL, USA
    Expert Opin Investig Drugs 21:395-401. 2012

Detail Information

Publications1

  1. doi request reprint Elvitegravir: a once-daily inhibitor of HIV-1 integrase
    Todd Wills
    Division of Infectious Disease and International Medicine, University of South Florida College of Medicine, 1 Tampa General Circle, Tampa, FL, USA
    Expert Opin Investig Drugs 21:395-401. 2012
    ..It is the second member of the HIV-1 IN inhibitor class, following raltegravir. Co-administration with a CYP3A inhibitor, such as ritonavir or cobicistat, substantially increases EVG plasma exposure and prolongs elimination half-life...